TotalMarketCap

Arrowhead Pharmaceuticals

ARWRNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$8.114 B

$57.44 -6.83%

Close of 6 Nov 2026

As of 6 Nov 2026, Arrowhead Pharmaceuticals (ARWR) has a market capitalization of $8.11B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$829.4M

#1624 by revenue

Earnings

-$1.63M

Loss-making

Shares outstanding

141,254,467

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #35Tg TherapeuticsTGTX$8.87B
  2. #36Protagonist TherapeuticsPTGX$8.76B
  3. #37Arrowhead PharmaceuticalsARWR$8.11B
  4. #38Corcept TherapeuticsCORT$7.86B
  5. #39CytokineticsCYTK$7.74B

What if Arrowhead Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$199,900.75

Per share 3,480× higher

Bitcoin $1.53T

$10,816.28

Per share 188× higher

Apple $5.02T

$35,508.84

Per share 618× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Arrowhead Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.